Currently holds a position at Urogen Pharma Ltd
Position | Company | Period |
---|---|---|
Chief Medical Officer | Urogen Pharma Ltd | Dec. 1, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-20 | 2024-03-18 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
12,000
-7.9%
14.05168,600 USD |
12,000 -7.9% | 14.05 | 168,600 USD | |
2024-02-02 | 2024-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
1,894
-1.2%
15.7429,812 USD |
1,894 -1.2% | 15.74 | 29,812 USD | |
2024-02-02 | 2024-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
758
-0.5%
15.7411,931 USD |
758 -0.5% | 15.74 | 11,931 USD | |
2024-02-02 | 2024-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
1,137
-0.8%
15.7417,896 USD |
1,137 -0.8% | 15.74 | 17,896 USD | |
2023-02-02 | 2023-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
661
-0.4%
10.126,689 USD |
661 -0.4% | 10.12 | 6,689 USD | |
2023-02-02 | 2023-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
991
-0.7%
10.1210,029 USD |
991 -0.7% | 10.12 | 10,029 USD | |
2023-02-02 | 2023-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
248
-0.2%
10.122,510 USD |
248 -0.2% | 10.12 | 2,510 USD | |
2022-11-02 | 2022-10-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
258
-1.1%
11.853,057 USD |
258 -1.1% | 11.85 | 3,057 USD | |
2022-08-25 | 2022-08-01 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
259
-1.1%
7.812,023 USD |
259 -1.1% | 7.81 | 2,023 USD | |
2022-05-03 | 2022-04-30 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
254
-1.1%
6.621,681 USD |
254 -1.1% | 6.62 | 1,681 USD | |
2022-02-02 | 2022-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
1,099
-4.5%
7.588,330 USD |
1,099 -4.5% | 7.58 | 8,330 USD | |
2022-02-02 | 2022-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
275
-1.2%
7.582,085 USD |
275 -1.2% | 7.58 | 2,085 USD | |
2022-01-28 | 2022-01-26 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
111
-0.5%
8.09898 USD |
111 -0.5% | 8.09 | 898 USD | |
2021-11-19 | 2021-11-18 |
Urogen Pharma Ltd
(URGN)
|
B Purchase |
160
+0.7%
13.102,096 USD |
160 +0.7% | 13.10 | 2,096 USD | |
2021-11-02 | 2021-11-01 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
258
-1.2%
17.164,427 USD |
258 -1.2% | 17.16 | 4,427 USD | |
2021-10-28 | 2021-10-27 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
107
-0.5%
16.321,746 USD |
107 -0.5% | 16.32 | 1,746 USD | |
2021-05-04 | 2021-04-30 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
243
-1.1%
20.004,860 USD |
243 -1.1% | 20.00 | 4,860 USD | |
2021-02-02 | 2021-01-31 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
1,076
-4.9%
22.0723,747 USD |
1,076 -4.9% | 22.07 | 23,747 USD | |
2021-01-26 | 2021-01-26 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
100
-0.5%
22.122,212 USD |
100 -0.5% | 22.12 | 2,212 USD | |
2020-12-07 | 2020-12-04 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
662
-3.2%
19.8513,141 USD |
662 -3.2% | 19.85 | 13,141 USD | |
2020-10-28 | 2020-10-26 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
101
-0.5%
20.952,116 USD |
101 -0.5% | 20.95 | 2,116 USD | |
2020-09-08 | 2020-09-04 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
348
-1.8%
20.207,030 USD |
348 -1.8% | 20.20 | 7,030 USD | |
2020-07-28 | 2020-07-27 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
70
-0.4%
23.511,646 USD |
70 -0.4% | 23.51 | 1,646 USD | |
2020-06-05 | 2020-06-04 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
349
-1.9%
27.519,602 USD |
349 -1.9% | 27.51 | 9,602 USD | |
2020-04-28 | 2020-04-27 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
70
-0.4%
24.351,705 USD |
70 -0.4% | 24.35 | 1,705 USD | |
2020-01-28 | 2020-01-27 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
322
-3.4%
29.159,386 USD |
322 -3.4% | 29.15 | 9,386 USD | |
2019-09-06 | 2019-09-04 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
343
-5.4%
33.9211,635 USD |
343 -5.4% | 33.92 | 11,635 USD | |
2019-03-22 | 2019-03-21 |
Urogen Pharma Ltd
(URGN)
|
B Purchase |
272
+6.3%
37.0110,066 USD |
272 +6.3% | 37.01 | 10,066 USD | |
2019-03-07 | 2019-03-06 |
Urogen Pharma Ltd
(URGN)
|
S Sale |
1,991
-31.5%
37.3074,264 USD |
1,991 -31.5% | 37.30 | 74,264 USD |